|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities: | |||||
| Net (loss) income | |||||
| Loss (gain) from discontinued operations, net of income taxes | |||||
| (Loss) income from continuing operations | |||||
| Adjustments to reconcile income from continuing operations to cash provided by continuing operating activities: | |||||
| Depreciation | |||||
| Amortization | |||||
| Stock-based compensation | |||||
| Pension and other post-retirement benefits expense | |||||
| Deferred income taxes | |||||
| Loss on deal contingent hedge | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Trade receivables, net and contract assets | |||||
| Inventories | |||||
| Accounts payable, trade and other | |||||
| Advance and progress payments | |||||
| Accrued pension and other post-retirement benefits, net | |||||
| Income taxes on gain from sale of AeroTech | |||||
| Other assets and liabilities, net | |||||
| Cash provided by continuing operating activities | |||||
| Cash flows from continuing investing activities: | |||||
| Acquisitions, net of cash acquired | |||||
| (Payments) proceeds from discontinued operations | |||||
| Investment in unconsolidated affiliate | |||||
| Capital expenditures | |||||
| Proceeds from disposal of assets | |||||
| Purchase of marketable securities | |||||
| Proceeds from sale of marketable securities | |||||
| Cash (required) provided by continuing investing activities | |||||
| Cash flows from continuing financing activities: | |||||
| Net proceeds (payments) from short-term debt | |||||
| Payment in connection with modification of credit facilities | |||||
| Repayment of domestic credit facility | |||||
| Net proceeds (payments) from domestic credit facilities, net of debt issuance cost | |||||
| Proceeds from Term Loan B, net of debt issuance costs | |||||
| Repayment of Term Loan B | |||||
| Payment of debt issuance costs related to the Marel Transaction | |||||
| Term Loan B and Domestic Credit Facility Amendment | |||||
| Marcel Transaction Debt | |||||
| Secured Debt | |||||
| Proceeds from issuance of 2030 convertible senior notes, net of debt issuance costs | |||||
| Purchase of convertible bond hedge | |||||
| Proceeds from sale of warrants | |||||
| Acquisition of noncontrolling interest of Marel | |||||
| Settlement of deal contingent hedge | |||||
| Proceeds from settlement of cross currency swaps | |||||
| Common stock repurchases | |||||
| Dividends | |||||
| Acquisition date earnout liability and other deferred acquisition payments | |||||
| Other | |||||
| Cash provided (required) by continuing financing activities | |||||
| Net (decrease) increase in cash from continuing operations | |||||
| Cash provided (required) by operating activities of discontinued operations, net | |||||
| Cash required by investing activities of discontinued operations, net | |||||
| Net cash provided (required) by discontinued operations | |||||
| Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Add: Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash from continuing operations, end of period | |||||
| Add: Cash, cash equivalents and restricted cash from discontinued operations, beginning of period | |||||
| Less: Cash, cash equivalents and restricted cash from discontinued operations, end of period | |||||
| Supplemental cash flow information for continuing operations: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Income taxes paid on gain from sale of AeroTech | |||||
| Non-cash investing in capital expenditures, accrued but not paid | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...